First HIFU patient treated at Henry Ford Hospital in Detroit

EDAP's Ablatherm^® Robotic HIFU Treats First Patient at Henry Ford Hospital in Detroit Read more

First HIFU patient treated at Allied Urological Services in New York City

First HIFU patient treated at Allied Urological Services in New York City with the Ablatherm^® Robotic HIFU device Read more

First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU

First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU at Sylvester Comprehensive Cancer Center, in Miami, Florida Read more

EDAP Announces Results of World's First Focal HIFU Trial

EDAP Announces Results of World's First Focal HIFU Trial Read more

EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center

EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center Read more

EDAP Receives Russian Regulatory Approval for Focal One® HIFU Device

EDAP Receives Russian Regulatory Approval for Focal One^® HIFU Device Read more

Installation of Ablatherm® Robotic HIFU at University of Southern California

EDAP Reports Installation of Ablatherm^® Robotic HIFU at University of Southern California Read more

EDAP Records First Three U.S. Orders for Ablatherm HIFU

EDAP Records First Three U.S. Orders for Ablatherm HIFU Read more

Ablatherm FDA approved

EDAP Receives FDA Approval for Ablatherm HIFU Read more

Focal One® HIFU Device Adopted by Medipole Group in France

EDAP's Focal One® HIFU Device Adopted by Medipole Group in France Read more